Back

Intravenous administration of IV-STATIN CARDIOSHIELD during myocardial infarction renders higher cardioprotection than oral atorvastatin given shortly after reperfusion: a translational CMR study

1 September 2019 (15:15 - 15:30)
Organised by:
Congress Presentation Part of: Young Investigator Award Session Thrombosis Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Guiomar Mendieta Badimon

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

3 More presentations in this session

Presentation thumbnail
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial
Miss T. de Vries (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
The prothrombotic transcriptome of reticulated platelets
Doctor D. Bongiovanni (Augsburg, DE)
Abstract Slides Video
Presentation thumbnail
Sirtuin 5 regulates arterial thrombosis by modulating endothelial plasminogen activator inhibitor-1
Doctor L. Liberale (Genova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award Session Thrombosis

The Event

Event poster

ESC Congress 2019

1 September 2019 15:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources